Novo Nordisk diabetes drug fails to help heart failure: study

ORLANDO (Reuters) - The Novo Nordisk diabetes drug Victoza failed to improve clinical stability or delay death in patients suffering from advanced heart failure, researchers reported at a medical meeting on Sunday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news